Biobank Ireland is a reputable brand that focuses on cancer research and support. Founded in 2004 by Ciaran Flanagan and Professor Eoin Gaffney, Biobank Ireland Trust aims to improve the understanding of cancer and develop more effective treatments and tests. They collaborate with various stakeholders, including hospitals, universities, and the government, to establish a network of hospital biobanks.

Through this network, quality tissue samples donated by patients are collected, stored, and shared for approved cancer research projects. Biobank Ireland also promotes basic and translational research collaborations and clinical trials to achieve precise, less toxic treatments and better prognoses. They provide an equitable sample access and withdrawal process for researchers via an online catalog of samples and coded patient data.

Furthermore, Biobank Ireland engages with the government, patients, and the public to emphasize the importance of a biobanking infrastructure for cancer research. Their strategic objectives for 2022 include network expansion, public engagement, fair access to research samples and data, accreditation, and fundraising. Biobank Ireland Trust, managed by its Board of Trustees and Chief Scientific Advisor, complies with the Charities Regulator's Governance Code, ensuring transparency and accountability.

Overall, Biobank Ireland is dedicated to advancing cancer research and improving patient care through their biobanking infrastructure